Business Wire

NY-THE-BODY-SHOP

11.5.2022 17:02:10 CEST | Business Wire | Press release

Share
The Body Shop and the United Nations Secretary-General’s Envoy on Youth Launch Global Collaboration Calling for More Young Voices in the Halls of Power

Millions of young people are missing from public life. With the climate crisis, global conflict and generational inequalities running rampant, the inputs, perspectives and representation of youth are needed more than ever.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220509005499/en/

Almost half the world's population is under 30. Yet, they make up only 2.6% of parliamentarians around the world**. The average age of a world leader is currently 62***. Of all the parliaments in the world, 37% do not have a single Member of Parliament (MP) under age 30** and less than 1% of these young MPs are women.

Young people have the right to be included in political decisions that affect them, however, numerous barriers prevent their participation. The Body Shop and the Office of the United Nations Secretary-General's Envoy on Youth are collaborating to change this through the global Be Seen Be Heard campaign, which seeks to create long-term structural changes to decision-making to be more inclusive of young people.

It is launched today with the release of a research piece titled Be Seen Be Heard: Understanding young people’s political participation’.

The research includes the largest-ever survey carried out by The Body Shop, covering 26 countries with 27,043 respondents. It found that 82% of people surveyed agree that political systems need drastic reform to be fit for the future.

Two in three people also agree that the age balance in politics is wrong, with 8 in 10 people of all ages believing the ideal voting age (the age when someone can first vote) is 16 to 18, despite that in most countries the voting age is 18 or over. A third of those under age 30 surveyed would consider running for office versus only a fifth of those over age 30. People across all age groups agree that more opportunities for younger people to have a say in policy development and/or change would make political systems better.

David Boynton, CEO of The Body Shop says, “Our position is clear. The world’s problems cannot be solved by the same people making the same choices. The majority of young people are positive about the future, and we need to hear their views and ideas inside the halls of power. We will use our global reach to galvanise awareness and support, as we have in the past.”

Jayathma Wickramanayake, the United Nations Secretary-General’s Envoy on Youth says, “The intergenerational gap in power, influence and trust constitutes one of the biggest challenges of our time. Participation is a right, and a lack of youth representation where decisions are made contributes to a growing mistrust towards political institutions and a sense of alienation from elected leaders, caused by policies that do not reflect the priorities of youth, mirror their concerns or speak their language. This campaign is an opportunity to change that.”

The report suggests that young people’s participation in public decision-making could be improved long-term by a number of initiatives including; lowering voting ages, increasing formal youth representation, removing barriers for young people to participate in public decision-making, simplifying registration for first-time voters and improving young people’s leadership skills.

The campaign is launching globally in May 2022 and will run until mid-2025, driven by action in over 2,600 Body Shop stores in 75 countries, across six continents.

More information here.

Ends

** https://www.ipu.org/our-impact/youth-empowerment/data-youth-participation

*** REIGN Dataset | REIGN (oefdatascience.github.io)

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye